These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 23820504)

  • 1. Evaluation of the diagnostic value of serum and tissue apoptotic cytokeratin-18 in patients with chronic hepatitis C.
    Abdel Haleem H; Zayed N; Abdel Hafez H; Fouad A; Akl M; Hassan M; Hammam O; Morsy A; Saleh A; Seyam M; Zakaria Z; Zakaria S
    Arab J Gastroenterol; 2013 Jun; 14(2):68-72. PubMed ID: 23820504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum apoptotic caspase activity as a marker of severity in HBeAg-negative chronic hepatitis B virus infection.
    Papatheodoridis GV; Hadziyannis E; Tsochatzis E; Chrysanthos N; Georgiou A; Kafiri G; Manolakopoulos S; Tiniakos DG; Giannousis I; Manesis EK; Archimandritis AJ
    Gut; 2008 Apr; 57(4):500-6. PubMed ID: 18025069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apoptotic cytokeratin 18 neoepitopes in serum of patients with chronic hepatitis C.
    Kronenberger B; Wagner M; Herrmann E; Mihm U; Piiper A; Sarrazin C; Zeuzem S
    J Viral Hepat; 2005 May; 12(3):307-14. PubMed ID: 15850472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum apoptotic caspase activity in chronic hepatitis C and nonalcoholic Fatty liver disease.
    Papatheodoridis GV; Hadziyannis E; Tsochatzis E; Georgiou A; Kafiri G; Tiniakos DG; Margariti K; Manolakopoulos S; Manesis EK; Archimandritis AJ
    J Clin Gastroenterol; 2010 Apr; 44(4):e87-95. PubMed ID: 19881359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apoptosis markers related to pathogenesis of pediatric chronic hepatitis C virus infection: M30 mirrors the severity of steatosis.
    Valva P; De Matteo E; Galoppo MC; Gismondi MI; Preciado MV
    J Med Virol; 2010 May; 82(6):949-57. PubMed ID: 20419808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of serum IgG, IgA and IgM levels as indicators of hepatic fibrosis in patients with chronic hepatitis C infection].
    Ortarık Z; Toyran A; Sen S; Mart Kömürcü SZ; Güvener E
    Mikrobiyol Bul; 2011 Apr; 45(2):296-305. PubMed ID: 21644073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of apoptotic caspase activation in sera from patients with chronic HCV infection is associated with fibrotic liver injury.
    Bantel H; Lügering A; Heidemann J; Volkmann X; Poremba C; Strassburg CP; Manns MP; Schulze-Osthoff K
    Hepatology; 2004 Nov; 40(5):1078-87. PubMed ID: 15486927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic liver disease and hepatitis C virus in Egyptian patients.
    El-Medany OM; El-Din Abdel Wahab KS; Abu Shady EA; Gad El-Hak N
    Hepatogastroenterology; 1999; 46(27):1895-903. PubMed ID: 10430366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic and serum levels of miR-122 after chronic HCV-induced fibrosis.
    Trebicka J; Anadol E; Elfimova N; Strack I; Roggendorf M; Viazov S; Wedemeyer I; Drebber U; Rockstroh J; Sauerbruch T; Dienes HP; Odenthal M
    J Hepatol; 2013 Feb; 58(2):234-9. PubMed ID: 23085648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue inhibitors of metalloproteinases in liver and serum/plasma in chronic active hepatitis C and HCV-induced cirrhosis.
    Böker KH; Pehle B; Steinmetz C; Breitenstein K; Bahr M; Lichtinghagen R
    Hepatogastroenterology; 2000; 47(33):812-9. PubMed ID: 10919037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 8-Hydroxy-2'-deoxy-guanosine is a risk factor for development of hepatocellular carcinoma in patients with chronic hepatitis C virus infection.
    Chuma M; Hige S; Nakanishi M; Ogawa K; Natsuizaka M; Yamamoto Y; Asaka M
    J Gastroenterol Hepatol; 2008 Sep; 23(9):1431-6. PubMed ID: 18854000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levels of serum markers of liver inflammation and fibrosis in patients with chronic hepatitis C virus infection according to HIV status and antiretroviral use.
    Connoy A; Turner J; Núñez M
    AIDS Res Hum Retroviruses; 2011 Jul; 27(7):719-25. PubMed ID: 21128862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Helicobacter pylori in patients with HCV-related chronic hepatitis and cirrhosis with or without hepatocellular carcinoma: possible association with disease progression.
    Esmat G; El-Bendary M; Zakarya S; Ela MA; Zalata K
    J Viral Hepat; 2012 Jul; 19(7):473-9. PubMed ID: 22676359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is serum alanine transaminase level a reliable marker of histological disease in chronic hepatitis C infection?
    Sanai FM; Benmousa A; Al-Hussaini H; Ashraf S; Alhafi O; Abdo AA; Alameri HF; Akbar HO; Bzeizi KI
    Liver Int; 2008 Aug; 28(7):1011-8. PubMed ID: 18384520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum cystatin C: a non-invasive marker of liver fibrosis or of current liver fibrogenesis in chronic hepatitis C? .
    Ladero JM; Cárdenas MC; Ortega L; González-Pino A; Cuenca F; Morales C; Lee-Brunner A
    Ann Hepatol; 2012; 11(5):648-51. PubMed ID: 22947524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum cytokine levels as putative prognostic markers in the progression of chronic HCV hepatitis to cirrhosis.
    Costantini S; Capone F; Guerriero E; Maio P; Colonna G; Castello G
    Eur Cytokine Netw; 2010 Dec; 21(4):251-6. PubMed ID: 21081303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AST/ALT ratio predicts cirrhosis in patients with chronic hepatitis C virus infection.
    Sheth SG; Flamm SL; Gordon FD; Chopra S
    Am J Gastroenterol; 1998 Jan; 93(1):44-8. PubMed ID: 9448172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic iron, liver steatosis and viral genotypes in patients with chronic hepatitis C.
    Sebastiani G; Vario A; Ferrari A; Pistis R; Noventa F; Alberti A
    J Viral Hepat; 2006 Mar; 13(3):199-205. PubMed ID: 16475996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated serum levels of caspase-cleaved cytokeratin 18 (CK18-Asp396) in patients with nonalcoholic steatohepatitis and chronic hepatitis C.
    Yilmaz Y; Dolar E; Ulukaya E; Akgoz S; Keskin M; Kiyici M; Yerci O; Oral AY; Gul CB; Gurel S; Nak SG; Gulten M
    Med Sci Monit; 2009 Apr; 15(4):CR189-93. PubMed ID: 19333204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of serum adipocytokines with insulin resistance and liver injury in patients with chronic hepatitis C genotype 4.
    Khattab MA; Eslam M; Aly MM; Shatat M; Hussen A; Moussa YI; Elsaghir G; Abdalhalim H; Aly A; Gaber S; Harrison SA
    J Clin Gastroenterol; 2012; 46(10):871-9. PubMed ID: 22664476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.